Intuitive Surgical Inc (ISRG) stock
ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3030% above fair value
$420.95−9.58 (-2.23%)
Close on Nov 18, 2026Market cap $145.92BP/E 50.9Yield –
Intuitive Surgical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Intuitive Surgical's operating income for the twelve months ending Sep 30, 2026 was $3.28B, up 16.6% year over year. For fiscal 2025 it was $2.95B, up 25.4% from the year before. Over ten years it grew 14.8% a year on average. The highest annual figure on record is $2.95B in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.95B | +25.4% |
| FY2024 | Dec 31, 2024 | $2.35B | +32.9% |
| FY2023 | Dec 31, 2023 | $1.77B | +12.0% |
| FY2022 | Dec 31, 2022 | $1.58B | -13.4% |
| FY2021 | Dec 31, 2021 | $1.82B | +73.5% |
| FY2020 | Dec 31, 2020 | $1.05B | -23.6% |
| FY2019 | Dec 31, 2019 | $1.37B | +14.6% |
| FY2018 | Dec 31, 2018 | $1.20B | +12.8% |
| FY2017 | Dec 31, 2017 | $1.06B | +11.9% |
| FY2016 | Dec 31, 2016 | $949.70M | +28.3% |
| FY2015 | Dec 31, 2015 | $740.00M | +35.8% |
| FY2014 | Dec 31, 2014 | $544.80M | -36.1% |
| FY2013 | Dec 31, 2013 | $852.50M | -2.9% |
| FY2012 | Dec 31, 2012 | $878.10M | +26.4% |
| FY2011 | Dec 31, 2011 | $694.80M | +25.1% |
| FY2010 | Dec 31, 2010 | $555.20M | +47.1% |
| FY2009 | Dec 31, 2009 | $377.40M | +21.4% |
| FY2008 | Dec 31, 2008 | $310.80M | +50.3% |
| FY2007 | Dec 31, 2007 | $206.74M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $592.60M | -22.0% |
| Q2 FY2026 | Jun 30, 2026 | $971.90M | +30.7% |
| Q1 FY2026 | Mar 31, 2026 | $855.30M | +48.0% |
| Q4 FY2025 | Dec 31, 2025 | $864.30M | +17.6% |
| Q3 FY2025 | Sep 30, 2025 | $759.70M | +31.6% |
| Q2 FY2025 | Jun 30, 2025 | $743.40M | +31.0% |
| Q1 FY2025 | Mar 31, 2025 | $578.10M | +23.2% |
| Q4 FY2024 | Dec 31, 2024 | $734.90M | +63.2% |
| Q3 FY2024 | Sep 30, 2024 | $577.30M | +23.9% |
| Q2 FY2024 | Jun 30, 2024 | $567.30M | +22.5% |
| Q1 FY2024 | Mar 31, 2024 | $469.40M | +21.1% |
| Q4 FY2023 | Dec 31, 2023 | $450.20M | +20.9% |
| Q3 FY2023 | Sep 30, 2023 | $465.80M | +16.8% |
| Q2 FY2023 | Jun 30, 2023 | $463.20M | +16.5% |
| Q1 FY2023 | Mar 31, 2023 | $387.60M | -5.0% |
| Q4 FY2022 | Dec 31, 2022 | $372.50M | -17.3% |
| Q3 FY2022 | Sep 30, 2022 | $398.90M | -9.9% |
| Q2 FY2022 | Jun 30, 2022 | $397.60M | -22.2% |
| Q1 FY2022 | Mar 31, 2022 | $408.10M | -2.1% |
| Q4 FY2021 | Dec 31, 2021 | $450.40M | +8.3% |
| Q3 FY2021 | Sep 30, 2021 | $442.60M | +63.7% |
| Q2 FY2021 | Jun 30, 2021 | $511.20M | +534.2% |
| Q1 FY2021 | Mar 31, 2021 | $416.80M | +47.3% |
| Q4 FY2020 | Dec 31, 2020 | $415.80M | +4.6% |
| Q3 FY2020 | Sep 30, 2020 | $270.40M | -26.1% |
| Q2 FY2020 | Jun 30, 2020 | $80.60M | -77.5% |
| Q1 FY2020 | Mar 31, 2020 | $283.00M | +12.2% |
| Q4 FY2019 | Dec 31, 2019 | $397.60M | +19.8% |
| Q3 FY2019 | Sep 30, 2019 | $365.70M | +16.7% |
| Q2 FY2019 | Jun 30, 2019 | $359.00M | +29.4% |
| Q1 FY2019 | Mar 31, 2019 | $252.20M | -8.9% |
| Q4 FY2018 | Dec 31, 2018 | $332.00M | +0.9% |
| Q3 FY2018 | Sep 30, 2018 | $313.30M | +11.7% |
| Q2 FY2018 | Jun 30, 2018 | $277.40M | +6.7% |
| Q1 FY2018 | Mar 31, 2018 | $276.70M | +43.1% |
| Q4 FY2017 | Dec 31, 2017 | $329.00M | +22.4% |
| Q3 FY2017 | Sep 30, 2017 | $280.60M | – |
| Q2 FY2017 | Jun 30, 2017 | $259.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $193.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $268.90M | – |
See a number that looks wrong?